SCHEMBL17786276

SCHEMBL17786276

CC(C)CCn1c(CO)nc2c1c(=O)n(C)c(=O)n2C

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 17/20 0.63
KMT2A Q03164 3/20 0.63
MEN1 O00255 2/20 0.63
MAPT P10636 2/20 0.60
LMNA P02545 1/20 0.60
TSHR P16473 4/20 0.58
NPSR1 Q6W5P4 4/20 0.58
USP2 O75604 2/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
MAPK1 P28482 1/20 0.58
GAA P10253 2/20 0.56
HPGD P15428 1/20 0.56
HTT P42858 2/20 0.52
HSD17B10 Q99714 1/20 0.52
MAOA P21397 2/20 0.51
MAOB P27338 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17786274 0.80 CYP1A2 (0.68) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL28061963 0.79 RXFP1 (0.59) KMT2AMEN1MAOAMAOBCYP2C19
SCHEMBL17207521 0.78 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1TSHRNPSR1
SCHEMBL17786283 0.78 TSHR (0.58) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL17207523 0.77 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1TSHRNPSR1
SCHEMBL17791583 0.77 ALDH1A1 (0.81) ALDH1A1KMT2AMEN1LMNATSHR
SCHEMBL17791573 0.76 ALDH1A1 (0.75) ALDH1A1KMT2AMEN1LMNATSHR
SCHEMBL17207512 0.75 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTTSHR
SCHEMBL17786253 0.75 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1MAPTLMNA
SCHEMBL17786233 0.75 ALDH1A1 (1.00) ALDH1A1KMT2AMEN1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016086008-A1 SMALL MOLECULE ALDEHYDE DEHYDROGENASE INHIBITORS AND METHODS OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-06-02 WO disclosed